Anticardiolipin antibodies in patients with rheumatoid arthritis and spondyloarthropathies treated with infliximab

被引：0
|
作者：
Gómez-Puerta, JA
Hernández, MV
Reverter, JC
Salvador, G
Vázquez, I
Graell, E
Rodriguez-Cros, JR
Gómez-Centeno, A
Cañete, JD
Sanmarti, R
机构：
[1] Hosp Clin Barcelona, Arthrit Unit, Dept Rheumatol, Barcelona, Spain
[2] Hosp Clin Barcelona, Haemostasia Dept, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [41] Changes in bone mineral density in patients with rheumatoid arthritis treated with infliximab
    Vis, M
    Wolbink, GJ
    Dijkmans, BAC
    Lems, WF
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 94 - 94
  • [42] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M. K.
    Rahman, M. U.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 168 - 168
  • [43] Healthcare costs for rheumatoid arthritis patients treated with abatacept, infliximab, or rituximab
    Chapman, Richard H.
    Smith, Daniel
    Semroc, Georgette N.
    Trivedi, Digisha N.
    Rosenblatt, Lisa C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S464 - S464
  • [44] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab plus methotrexate
    Doyle, M.
    Rahman, M.
    Han, C.
    Han, J.
    Giles, J. T.
    Bingham, C. O.
    Bathon, J. M.
    RHEUMATOLOGY, 2008, 47 : II39 - II40
  • [45] Treatment with tumour necrosis factor a antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies
    Jonsdottir, T
    Forslid, J
    van Vollenhoven, A
    Harju, A
    Brannemark, S
    Klareskog, L
    van Vollenhoven, RF
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) : 1075 - 1078
  • [46] Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice:: adverse events and other reasons for discontinuation of treatment
    Levalampi, T.
    Korpela, M.
    Vuolteenaho, K.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (01) : 6 - 12
  • [47] Intra-articular injection of infliximab in resistant inflamed joints of rheumatoid arthritis and spondyloarthropathies
    Chatzigiannis, I
    Kakavouli, G
    Sakellariou, G
    Vezyridis, C
    Voudouris, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 418 - 419
  • [48] Effects of antibodies to infliximab on ACR response in patients with rheumatoid arthritis in the ATTRACT study
    Wagner, CL
    Clair, EWS
    Han, CL
    Ford, J
    Schantz, A
    Maini, RN
    Lipsky, PE
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S132 - S132
  • [49] Reactions to infliximab in patients with rheumatoid arthritis
    Sakellariou, GT
    Chatzigiannis, I
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1411 - 1412
  • [50] Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: Preliminary data
    Delaunay, C
    Farrenq, V
    Marini-Portugal, A
    Cohen, JD
    Chevalier, X
    Claudepierre, P
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (11) : 2183 - 2185
12345